Cleared Traditional

K252279 - Sterile Hypodermic Syringe for Single Use (20ml, 30ml, 50ml, 60ml)

K252279 is an FDA 510(k) clearance for Sterile Hypodermic Syringe for Single U..., manufactured by Chirana T.Injecta,A.S.. The device is a Class 2 General Hospital device with product code FMF cleared through the Traditional 510(k) pathway after a 269-day FDA review.

K252279 · Chirana T.Injecta,A.S. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2026
Decision
269d
Days
Class 2
Risk

K252279 is an FDA 510(k) clearance for the Sterile Hypodermic Syringe for Single Use (20ml, 30ml, 50ml, 60ml). Classified as Syringe, Piston (product code FMF), Class II - Special Controls.

Submitted by Chirana T.Injecta,A.S. (Stará Turá, SK). The FDA issued a Cleared decision on April 17, 2026 after a review of 269 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5860 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Chirana T.Injecta,A.S. devices

FDA 510(k) Submission Details - K252279

510(k) Number K252279 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 22, 2025
Decision Date April 17, 2026
Days to Decision 269 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
140d slower than avg
Panel avg: 129d · This submission: 269d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FMF Device Classification - Class 2, Special Controls

Product Code FMF Syringe, Piston
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5860
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FMF Syringe, Piston

All 480
Devices cleared under the same product code (FMF) and FDA review panel - the closest regulatory comparables to K252279.
Sol-Glide Safety Needle
K253110 · Sol-Millennium Medical, Inc. · Jun 2026
Profoject™ Safety Needle
K260514 · CMT Health PTE., Ltd. · Jun 2026
Sofjec (Single use Needle)
K253112 · Hlb Lifescience Co., Ltd. · May 2026
Profoject™ Insulin Syringes
K253068 · CMT Health PTE., Ltd. · Feb 2026
Instylla Delivery Kit
K253769 · Instylla, Inc. · Dec 2025
DuoprossTM Smart Cap (Type I)
K252518 · Duopross Meditech Corporate · Dec 2025